Oreste Villani

1.3k total citations
35 papers, 635 citations indexed

About

Oreste Villani is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Oreste Villani has authored 35 papers receiving a total of 635 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Hematology, 15 papers in Genetics and 12 papers in Molecular Biology. Recurrent topics in Oreste Villani's work include Chronic Lymphocytic Leukemia Research (12 papers), Multiple Myeloma Research and Treatments (9 papers) and Lymphoma Diagnosis and Treatment (9 papers). Oreste Villani is often cited by papers focused on Chronic Lymphocytic Leukemia Research (12 papers), Multiple Myeloma Research and Treatments (9 papers) and Lymphoma Diagnosis and Treatment (9 papers). Oreste Villani collaborates with scholars based in Italy, Switzerland and Netherlands. Oreste Villani's co-authors include Pellegrino Musto, Giuseppe Pietrantuono, Giovanna Mansueto, Giovanni D’Arena, Roberto Guariglia, Luciana De Luca, Francesco La Rocca, Stefania Trino, Antonella Caivano and Ilaria Laurenzana and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Oreste Villani

30 papers receiving 626 citations

Peers

Oreste Villani

HEMAT

GENET

ONCOL

Parva Bhatt United States

J. Erika Haydu United States

Aleksandra Rizo United States

Chung Hoow Kok Australia

Miriam Belmonte United Kingdom

Stéphanie Struski France

Camelia Iancu‐Rubin United States

Baskar Ramdas United States

Daniela Intini Italy

Brooke Snetsinger Canada

Parva Bhatt United States

Oreste Villani

441 ×1.1

HEMAT

289 ×0.9

241 ×1.2

GENET

75 ×0.5

ONCOL

126 ×1.1

Citations per year, relative to Oreste Villani Oreste Villani (= 1×) peers Parva Bhatt

Countries citing papers authored by Oreste Villani

Since Specialization

Citations

This map shows the geographic impact of Oreste Villani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oreste Villani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oreste Villani more than expected).

Fields of papers citing papers by Oreste Villani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Oreste Villani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oreste Villani. The network helps show where Oreste Villani may publish in the future.

Co-authorship network of co-authors of Oreste Villani

This figure shows the co-authorship network connecting the top 25 collaborators of Oreste Villani. A scholar is included among the top collaborators of Oreste Villani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Oreste Villani. Oreste Villani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

D’Arena, Giovanni, Candida Vitale, Giuseppe Pietrantuono, et al.. (2024). What Does Atypical Chronic Lymphocytic Leukemia Really Mean? A Retrospective Morphological and Immunophenotypic Study. Cancers. 16(2). 469–469. 3 indexed citations

D’Arena, Giovanni, Fiorella D’Auria, Luciana De Luca, et al.. (2023). Preliminary analysis of double‐negative T, double‐positive T, and natural killer T‐like cells in B‐cell chronic lymphocytic leukemia. Cancer Medicine. 12(12). 13241–13255. 5 indexed citations

D’Auria, Fiorella, Vitina Grieco, Teodora Statuto, et al.. (2022). Case report: Hematologic malignancies concomitant diagnosis of hairy cell leukemia and chronic lymphocytic leukemia: A rare association. Frontiers in Oncology. 12. 1069977–1069977.

Laurenzana, Ilaria, Stefania Trino, Daniela Lamorte, et al.. (2021). Analysis of Amount, Size, Protein Phenotype and Molecular Content of Circulating Extracellular Vesicles Identifies New Biomarkers in Multiple Myeloma. International Journal of Nanomedicine. Volume 16. 3141–3160. 21 indexed citations

Rocca, Francesco La, Vitina Grieco, Vitalba Ruggieri, et al.. (2020). Superiority of Droplet Digital PCR Over Real-Time Quantitative PCR for JAK2 V617F Allele Mutational Burden Assessment in Myeloproliferative Neoplasms: A Retrospective Study. Diagnostics. 10(3). 143–143. 14 indexed citations

D’Arena, Giovanni, Vincenzo De Feo, Giuseppe Pietrantuono, et al.. (2020). CD200 and Chronic Lymphocytic Leukemia: Biological and Clinical Relevance. Frontiers in Oncology. 10. 584427–584427. 20 indexed citations

Statuto, Teodora, Fiorella D’Auria, Luigi Del Vecchio, et al.. (2020). <p>Atypical Mature T-Cell Neoplasms: The Relevance of the Role of Flow Cytometry</p>. OncoTargets and Therapy. Volume 13. 7605–7614. 2 indexed citations

Statuto, Teodora, Giovanni Calice, Oreste Villani, et al.. (2019). Cytofluorimetric and immunohistochemical comparison for detecting bone marrow infiltration in non-Hodgkin lymphomas: a study of 354 patients. Leukemia Research. 88. 106267–106267. 7 indexed citations

Luca, Luciana De, Stefania Trino, Ilaria Laurenzana, et al.. (2017). Knockdown of miR-128a induces Lin28a expression and reverts myeloid differentiation blockage in acute myeloid leukemia. Cell Death and Disease. 8(6). e2849–e2849. 33 indexed citations

10.

Rocca, Francesco La, Irma Airoldi, Emma Di Carlo, et al.. (2017). EphA3 targeting reduces in vitro adhesion and invasion and in vivo growth and angiogenesis of multiple myeloma cells. Cellular Oncology. 40(5). 483–496. 15 indexed citations

11.

Luca, Luciana De, Giovanni D’Arena, Vittorio Simeon, et al.. (2016). Characterization and Prognostic Relevance of Circulating Microvesicles in Chronic Lymphocytic Leukemia. Blood. 128(22). 4375–4375. 1 indexed citations

12.

Caivano, Antonella, Francesco La Rocca, Vittorio Simeon, et al.. (2016). MicroRNA-155 in serum-derived extracellular vesicles as a potential biomarker for hematologic malignancies - a short report. Cellular Oncology. 40(1). 97–103. 74 indexed citations

13.

Cerrato, Chiara, Maria Teresa Petrucci, Mariella Genuardi, et al.. (2013). A Phase II Study With Carfilzomib, Cyclophosphamide and Dexamethasone (CCd) For Newly Diagnosed Multiple Myeloma. Blood. 122(21). 685–685. 7 indexed citations

14.

D’Arena, Giovanni, Roberto Guariglia, Oreste Villani, et al.. (2013). An Urologic Face of Chronic Lymphocytic Leukemia:Sequential Prostatic and Penis Localization. Mediterranean Journal of Hematology and Infectious Diseases. 5(1). e2013008–e2013008. 4 indexed citations

15.

D’Arena, Giovanni, Marica Gemei, Luigiana Luciano, et al.. (2012). Chronic Lymphocytic Leukemia After Chronic Myeloid Leukemia in the Same Patient: Two Different Genomic Events and a Common Treatment?. Journal of Clinical Oncology. 30(32). e327–e330. 8 indexed citations

16.

D’Arena, Giovanni, Paolo G. Gobbi, Chiara Broglia, et al.. (2011). Pamidronate versus observation in asymptomatic myeloma: final results with long-term follow-up of a randomized study. Leukemia & lymphoma. 52(5). 771–775. 74 indexed citations

17.

Guariglia, Roberto, Maria Carmen Martorelli, Oreste Villani, et al.. (2010). Positive effects on hematopoiesis in patients with myelodysplastic syndrome receiving deferasirox as oral iron chelation therapy: A brief review. Leukemia Research. 35(5). 566–570. 50 indexed citations

18.

Musto, Pellegrino, Luca Maurillo, Alessandra Spagnoli, et al.. (2010). Azacitidine for the treatment of lower risk myelodysplastic syndromes. Cancer. 116(6). 1485–1494. 75 indexed citations

19.

Musto, Pellegrino, Potito Rosario Scalzulli, Elisabetta Terruzzi, et al.. (2007). Peg-filgrastim versus filgrastim after autologous stem cell tranplantation: Case-control study in patients with multiple myeloma and review of the literature. Leukemia Research. 31(11). 1487–1493. 11 indexed citations

20.

Guariglia, Roberto, Giuseppe Pietrantuono, Oreste Villani, et al.. (2007). Combination of Rituximab, Bortezomib and Hyper-Fractionated Cyclophosphamide (RBC) in “True” Elderly Patients with Advanced Mantle Cell Lympoma.. Blood. 110(11). 4448–4448.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact